
S1 Ep5: OT Roundup Ep. 5: FDA NAION warning for GLP-1 drugs, LEMS vs ocular MG, Eyedaptic Eva, AFib
Notes de l’épisode
On this episode of OT Roundup, Ophthalmology Times covers the FDA's new NAION warning for GLP-1 receptor agonists, with an Expert Insight from Veeral Sheth, MD, University Retina. Also in this episode: how to tell Lambert-Eaton myasthenic syndrome from ocular myasthenia gravis, a new AI assistant from Eyedaptic for patients with retinal disease, and a study linking retinal imaging to atrial fibrillation. Links below!
1. FDA requires NAION warning across the GLP-1 receptor agonist class
2. Distinguishing Lambert-Eaton myasthenic syndrome from ocular myasthenia gravis in the eye clinic
3. Eyedaptic launches Eva, an agentic AI visual assistant for patients with retinal disease
4. Retinal imaging as a window into atrial fibrillation